During the past decade, Research Integrity, LLC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 29 clinical trials were completed, i.e. on average, 126.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 15 clinical trials were completed. i.e. 136.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Integrity, LLC" #1 sponsor was "Pfizer" with 5 trials, followed by "Bayer" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "NewAmsterdam Pharma" with 3 trials sponsored and "Bausch Health Americas, Inc." with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Integrity, LLC" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Arkios BioDevelopment International" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Research Integrity, LLC" are "Cardiovascular Disease" (4 trials), "Heart Failure" (4 trials), "Atrial Fibrillation" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Chronic Idiopathic Constipation" (2 trials). Many other conditions were trialed in "Research Integrity, LLC" in a lesser frequency.

Most popular intervention types in "Research Integrity, LLC" are "Drug" (39 trials), "Other" (4 trials), "Device" (3 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Obicetrapib" (3 trials), "Apixaban" (2 trials), "Empagliflozin" (2 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Research Integrity, LLC" are 45 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Research Integrity, LLC". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Research Integrity, LLC, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Research Integrity, LLC, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".